Vimarsana
Biggest News Aggregation in the World

Page 28 - Cm Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Management Today - Breaking & Trending Today

BML Capital Management LLC Buys Shares of 7,067,179 Adverum Biotechnologies, Inc. (NASDAQ:ADVM) - Vimarsana News

BML Capital Management LLC Buys Shares of 7,067,179 Adverum Biotechnologies, Inc. (NASDAQ:ADVM)

BML Capital Management LLC bought a new stake in Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 7,067,179 shares of the biotechnology company’s stock, valued at approximately $4,095,000. Adverum Biotechnologies comprises about 3.9% of […]

CymaBay Therapeutics (NASDAQ:CBAY) Raised to "Hold" at StockNews.com - Vimarsana News

CymaBay Therapeutics (NASDAQ:CBAY) Raised to "Hold" at StockNews.com

StockNews.com upgraded shares of CymaBay Therapeutics (NASDAQ:CBAY – Get Rating) from a sell rating to a hold rating in a report issued on Tuesday morning. Several other brokerages have also issued reports on CBAY. Cantor Fitzgerald upped their price target on CymaBay Therapeutics from $13.00 to $15.00 in a research note on Tuesday, May 16th. […]

Deere & Company (NYSE:DE) PT Lowered to $445.00 at Robert W. Baird - Vimarsana News

Deere & Company (NYSE:DE) PT Lowered to $445.00 at Robert W. Baird

Shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) have received an average rating of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price […]

Paratek Pharmaceuticals (NASDAQ:PRTK) Downgraded by StockNews.com - Vimarsana News

Paratek Pharmaceuticals (NASDAQ:PRTK) Downgraded by StockNews.com

StockNews.com downgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a hold rating in a report issued on Saturday. Other equities research analysts have also recently issued reports about the company. HC Wainwright lowered their target price on Paratek Pharmaceuticals from $10.00 to $6.00 in a research note on Wednesday, […]

Adverum Biotechnologies (NASDAQ:ADVM) Upgraded by StockNews.com to Hold - Vimarsana News

Adverum Biotechnologies (NASDAQ:ADVM) Upgraded by StockNews.com to Hold

StockNews.com upgraded shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) from a sell rating to a hold rating in a research report released on Saturday morning. Separately, LADENBURG THALM/SH SH started coverage on shares of Adverum Biotechnologies in a report on Tuesday, March 7th. They issued a buy rating and a $2.00 target price on […]